New Trials in Breast Cancer: Could Your Patient Benefit?
Several new clinical trials in breast cancer have opened in recent months. Perhaps one of your patients could benefit from taking part? Human epidermal growth factor receptor 2–positive (HER2+) or HER2-low unresectable or metastatic breast cancer. Adults with this type of breast cancer who have received one to three chemotherapies may be eligible for a …
Read More
0
